⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCUL News
Ocular Therapeutix, Inc.
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
globenewswire.com
OCUL
Form 8-K
sec.gov
OCUL
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
globenewswire.com
OCUL
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
globenewswire.com
OCUL
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
prnewswire.com
GILD
REGN
AMGN
JNJ
MRK
ALKS
APLS
EYPT
OCUL
VRTX
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Form 8-K
sec.gov
OCUL
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
OCUL